FNY Investment Advisers’s Traws Pharma TRAW Stock Holding History

FNY Investment Advisers’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-267	Closed	-$56K	–	630
2020 Q2	$56K	Buy	+267	New	+$40.8K	0.03%	198

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

FNY Investment Advisers's TRAW Position: Q3 2020 in Review

FNY Investment Advisers sold out of Traws Pharma (TRAW) in Q3 2020, closing a stake of 267 shares — an estimated $56K sold.

FNY Investment Advisers first reported a position in TRAW in Q2 2020 and held it in 1 quarter. The position peaked at $56K in Q2 2020. 30 funds tracked by Wall St. Rank hold TRAW as of Q3 2020.

FNY Investment Advisers reported no remaining Traws Pharma position as of Q3 2020 after selling out during the quarter.
FNY Investment Advisers sold 267 Traws Pharma shares in Q3 2020, an estimated $56K.
FNY Investment Advisers first reported a position in Traws Pharma in Q2 2020 and held it in 1 quarter.
FNY Investment Advisers's Traws Pharma position peaked at $56K in Q2 2020.
30 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2020.

Based on FNY Investment Advisers's 13F filing for Q3 2020, filed 9 Oct 2020.